A $10.3 million grant from the California Institute for Regenerative Medicine (CIRM), the state’s stem cell agency, will fund a multi-UC effort to better understand neuropsychiatric disorders. One in ...

A live webcast of the presentations will be available on the “Investors” section under the “ Events ” section of the Company’s website at https://lbpharma.us/ where a replay of the webcasts will be ...

A large cohort study showed no association between use of acid-suppressant medications in pregnancy and neuropsychiatric outcomes in offspring after controlling for familial factors. Initial analyses ...

What do depression, Alzheimer's disease and autism have in common? Well, according to new research, they may all be underpinned by an increasing level of acidity in our brains. Scientists have long ...

A Georgia Tech doctoral student’s dissertation could help physicians diagnose neuropsychiatric disorders, including schizophrenia, autism, and Alzheimer’s disease. Instead of relying on traditional ...

In a genetic association study, investigators integrated data from genome-wide association studies of various disorders with retinal transcriptomic data. Findings revealed that the polygenic risk of ...

GH Research (NASDAQ:GHRS) draws attention after valuation update as biotechnology activity aligns with Nasdaq futures market trends.

Neuropsychiatric disorders are becoming increasingly prevalent. Given their complex and multifactorial pathogenesis, there is an urgent need for effective and targeted therapies that can improve ...

Psilocybin—the psychoactive compound in "magic mushrooms"—is gaining scientific attention for its potential in treating neuropsychiatric conditions including depression, anxiety, substance use ...